Skip to main content

Table 1 Distribution of demographic, reproductive, and lifestyle risk factors by race/ethnicity in the combined LACE and Pathways Studies (n = 2544)

From: Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors

 

White Total n = 1943 n (%)

African American Total n = 155 n (%)

Asian Total n = 189 n (%)

Hispanic Total n = 197 n (%)

Other Total n = 54 n (%)

Pvaluea

Age at diagnosis (years)

     

< 0.0001

   < 50

389 (20.0)

43 (27.7)

61 (32.3)

67 (34.0)

13 (24.1)

 

   50 to 64

879 (45.2)

80 (51.6)

87 (46.0)

80 (40.6)

29 (53.7)

 

   ≥ 65

675 (34.7)

32 (20.6)

41 (21.7)

50 (25.4)

12 (22.2)

 

   mean (± standard deviation)

59.8 (11.2)

56.2 (10.7)

54.8 (11.0)

55.7 (12.4)

57.7 (9.8)

 

Menopausal status

     

< 0.0001

   Postmenopausal

1,330 (75.6)

90 (71.4)

104 (59.1)

117 (65.4)

35 (72.9)

 

   Premenopausal

430 (24.4)

36 (28.6)

72 (40.9)

62 (34.6)

13 (27.1)

 

Family history

     

0.001

   No

1,503 (77.4)

133 (85.8)

163 (86.2)

167 (84.8)

41 (75.9)

 

   Yes

440 (22.6)

22 (14.2)

26 (13.8)

30 (15.2)

13 (24.1)

 

Parity

     

0.006

   Nulliparous

343 (17.7)

22 (14.2)

46 (24.3)

31 (15.7)

9 (16.7)

 

   1 to 2 children

894 (46.0)

67 (43.2)

93 (49.2)

79 (40.1)

31 (57.4)

 

   ≥ 3 children

706 (36.3)

66 (42.6)

50 (26.5)

87 (44.2)

14 (25.9)

 

Age at first full-term pregnancy (years)

     

< 0.0001

   Nulliparous

343 (17.7)

22 (14.3)

46 (24.3)

31 (15.8)

9 (16.7)

 

   < 26

1,020 (52.6)

113 (73.4)

61 (32.3)

119 (60.7)

28 (51.9)

 

   ≥ 26

578 (29.8)

19 (12.3)

82 (43.4)

46 (23.5)

17 (31.5)

 

Lifetime duration of lactation

     

0.215

   Never

908 (47.3)

92 (59.7)

81 (44.3)

91 (48.1)

25 (47.2)

 

   0 to 3 months

279 (14.5)

19 (12.3)

31 (16.9)

25 (13.2)

8 (15.1)

 

   ≥ 4 months

733 (38.2)

43 (27.9)

71 (38.8)

73 (38.6)

20 (37.7)

 

Alcohol use

     

< 0.0001

   Never

675 (39.9)

77 (67.5)

116 (75.3)

93 (62.4)

28 (57.1)

 

   Ever

1,016 (60.1)

37 (32.5)

38 (24.7)

56 (37.6)

21 (42.9)

 

Smoking history (years)

     

< 0.0001

   Never

925 (48.0)

73 (47.4)

148 (78.3)

113 (57.4)

22 (40.7)

 

   ≤ 10

269 (14.0)

17 (11.0)

13 (6.9)

33 (16.8)

6 (11.1)

 

   11 to 19

169 (8.8)

10 (6.5)

8 (4.2)

6 (3.0)

5 (9.3)

 

   ≥ 20

563 (29.2)

54 (35.1)

20 (10.6)

45 (22.8)

21 (38.9)

 

Hormone replacement therapy (postmenopausal women only)

      

   Never

310 (23.8)

37 (42.1)

47 (45.6)

37 (32.2)

12 (34.3)

 

   Ever

994 (76.2)

51 (57.9)

56 (54.4)

78 (67.8)

23 (65.7)

 

Oral contraceptive use

     

< 0.0001

   Never

638 (33.8)

40 (26.7)

100 (55.9)

72 (37.7)

16 (30.2)

 

   Ever

1,252 (66.2)

110 (73.3)

79 (44.1)

119 (62.3)

37 (69.8)

 

Body mass index (kg/m2)b

     

< 0.0001

   < 25

835 (43.4)

31 (20.0)

119 (63.3)

63 (32.5)

20 (37.0)

 

   25 to 29

600 (31.1)

48 (31.0)

46 (24.5)

64 (33.0)

14 (25.9)

 

   ≥ 30

491 (25.5)

76 (49.0)

23 (12.2)

67 (34.5)

20 (37.0)

 
  1. a From Pearson chi-square test across racial/ethnic categories.
  2. b Body mass index one year pre-diagnosis (LACE) and around diagnosis (Pathways).